Current Psychiatry Reports

, Volume 7, Issue 6, pp 441–446 | Cite as

The impact of residual symptoms on outcome of major depression

  • Noel Kennedy
  • Kevin Foy

Abstract

Unipolar depression should be viewed as a chronic illness with multiple phases rather than as a relapsing-remitting disorder. Incomplete remission from depression is common, with approximately one third of patients continuing to have residual depression at remission. Patients who have had a depressive episode spend more time with residual depressive symptoms than with major depression long term. The presence of residual symptomatology after an episode of depression is associated with an increased risk of short-term relapse, a long-term chronic course, higher risk of suicide attempts, poor social functioning, and poor outcome of comorbid medical illnesses.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lee AS, Murray RM: The long-term outcome of Maudsley depressives. Br J Psychiatry 1988, 153:741–751. In this seminal long-term study of outcomes of depression using actuarial methods, 89 consecutive admissions with depression in a tertiary referral center were followed up after 18 years. Less than 20% had remained well, one third had suffered an unnatural death or severe chronic disability and a high proportion suffered an unnatural death.PubMedCrossRefGoogle Scholar
  2. 2.
    Keller MB, Lavori PW, Mueller TI, et al.: Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992, 49:809–816.PubMedGoogle Scholar
  3. 3.
    Kiloh LG, Andrews G, Neilson M: The long-term outcome of depressive illness. Br J Psychiatry 1988, 153:752–757.PubMedGoogle Scholar
  4. 4.
    Lee AS: Better outcomes for depressive disorders? Psychol Med 2003, 33:769–774.PubMedCrossRefGoogle Scholar
  5. 5.
    Judd LL, Akiskal HS, Maser JD, et al.: A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998, 55:694–700. The weekly symptom level of 431 patients with major depression at five centers was rated prospectively over a period of 12 years. The amount of time spent at each level was rated. Patients spent 43% of time at combined minor depressive or subsyndromal symptom level, three times more than at a major depression level. Symptom levels changed on average twice per year.PubMedCrossRefGoogle Scholar
  6. 6.
    Paykel ES, Ramana R, Cooper Z, et al.: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995, 25:1171–1180. Seventy patients with major depressive episodes were followed-up longitudinally after remission and interviewed every 3 months over 2 years. Residual symptoms were present in 32% of the subjects. The nature of these symptoms is described, as is the proportion relapsing.PubMedGoogle Scholar
  7. 7.
    Kennedy N, Abbott R, Paykel ES: Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004, 184:330–336.PubMedCrossRefGoogle Scholar
  8. 8.
    Frank E, Prien RF, Jarrett RB, et al.: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991, 48:851–855. This paper defined important points in the natural history of depressive illness, including remission, partial remission and relapse.PubMedGoogle Scholar
  9. 9.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  10. 10.
    World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization; 1992.Google Scholar
  11. 11.
    Fava GA: Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry 2003, 64:123–133.PubMedCrossRefGoogle Scholar
  12. 12.
    Fava GA, Freyberger HJ, Bech P, et al.: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995, 63:1–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Post RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992, 149:999–1010.PubMedGoogle Scholar
  14. 14.
    Benazzi F: Inter-episode mood lability in mood disorders: residual symptom or natural course of illness? Psychiatry Clin Neurosci 2004, 58:480–486.PubMedCrossRefGoogle Scholar
  15. 15.
    MacEwan GW, Remick RA: Treatment resistant depression: a clinical perspective. Can J Psychiatry 1988, 33:788–792.PubMedGoogle Scholar
  16. 16.
    Thase ME, Simons AD, McGeary J, et al.: Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992, 149:1046–1052.PubMedGoogle Scholar
  17. 17.
    Cornwall PL, Scott J: Partial remission in depressive disorders. Acta Psychiatr Scand 1997, 95:265–271.PubMedGoogle Scholar
  18. 18.
    Van Londen L, Molenaar RP, Goekoop JG, et al.: Three-to 5-year prospective follow-up of outcome in major depression. Psychol Med 1998, 28:731–735.PubMedCrossRefGoogle Scholar
  19. 19.
    Faravelli C, Ambonetti A, Pallanti S, Pazzagli A: Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986, 143:888–891.PubMedGoogle Scholar
  20. 20.
    Pintor L, Gasto C, Navarro V, et al.: Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord 2003, 73:237–244.PubMedCrossRefGoogle Scholar
  21. 21.
    Pintor L, Torres X, Navarro V, et al.: Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord 2004, 82:291–296.PubMedCrossRefGoogle Scholar
  22. 22.
    Mueller TI, Leon AC, Keller MB, et al.: Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999, 156:1000–1006.PubMedGoogle Scholar
  23. 23.
    Judd LL, Akiskal HS, Maser JD, et al.: Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998, 50:97–108.PubMedCrossRefGoogle Scholar
  24. 24.
    Judd LL, Paulus MJ, Schettler PJ, et al.: Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000, 157:1501–1504.PubMedCrossRefGoogle Scholar
  25. 25.
    Kennedy N, Paykel ES: Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 2004, 80:135–144.PubMedCrossRefGoogle Scholar
  26. 26.
    Coryell W, Keller M, Endicott J, et al.: Bipolar II illness: course and outcome over a five-year period. Psychol Med 1989, 19:129–141.PubMedCrossRefGoogle Scholar
  27. 27.
    Kennedy N, Abbott R, Paykel ES: Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med 2003, 33:791–802. This paper describes a poor long-term outcome of depression in a more recent cohort despite high levels of pharmacological and psychologic treatments over follow-up. Social functioning also was poor but seemed to have improved compared with earlier studies.CrossRefGoogle Scholar
  28. 28.
    Judd LL, Paulus MP, Wells KB, Rapaport MH: Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996, 153:1411–1417.PubMedGoogle Scholar
  29. 29.
    Judd LL, Akiskal HS, Zeller PJ, et al.: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000, 57:375–380.PubMedCrossRefGoogle Scholar
  30. 30.
    Coryell W, Scheftner W, Keller M, et al.: The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993, 150:720–727.PubMedGoogle Scholar
  31. 31.
    Furukawa TA, Takeuchi H, Hiroe T, et al.: Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand 2001, 103:257–261.PubMedCrossRefGoogle Scholar
  32. 32.
    Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 33:766–771.PubMedGoogle Scholar
  33. 33.
    Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P: Longterm social functioning after severe depression: a review. Bipol Disord, In press.Google Scholar
  34. 34.
    Ormel J, Oldehinkel AJ, Nolen WA, Vollebergh W: Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects. Arch Gen Psychiatry 2004, 61:387–392.PubMedCrossRefGoogle Scholar
  35. 35.
    Bloom BS: Prevalence and economic effects of depression. Manag Care 2004, 13:9–16.PubMedGoogle Scholar
  36. 36.
    Han D, Wang EC: Remission from depression: a review of venlafaxine clinical and economic evidence. Pharmacoeconomics 2005, 23:567–581.PubMedCrossRefGoogle Scholar
  37. 37.
    Goldney RD, Fisher LJ, Dal GE, Taylor AW: Subsyndromal depression: prevalence, use of health services and quality of life in an Australian population. Soc Psychiatry Psychiatr Epidemiol 2004, 39:293–298.PubMedCrossRefGoogle Scholar
  38. 38.
    Simon GE, Revicki D, Heiligenstein J, et al.: Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry 2000, 22:153–162.PubMedCrossRefGoogle Scholar
  39. 39.
    Zimmerman M, Pfohl B, Coryell WH, et al.: Major depression and personality disorder. J Affect Disord 1991, 22:199–210.PubMedCrossRefGoogle Scholar
  40. 40.
    Shea MT, Leon AC, Mueller TI, et al.: Does major depression result in lasting personality change? Am J Psychiatry 1996, 153:1404–1410.PubMedGoogle Scholar
  41. 41.
    Ormel J, Oldehinkel AJ, Vollebergh W: Vulnerability before, during, and after a major depressive episode: a 3-wave population-based study. Arch Gen Psychiatry 2004, 61:990–996.PubMedCrossRefGoogle Scholar
  42. 42.
    O’Leary D, Paykel E, Todd C, Vardulaki K: Suicide in primary affective disorders revisited: a systematic review by treatment era. J Clin Psychiatry 2001, 62:804–811.PubMedCrossRefGoogle Scholar
  43. 43.
    Sokero TP, Melartin TK, Rytsala HJ, et al.: Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry 2005, 186:314–318.PubMedCrossRefGoogle Scholar
  44. 44.
    Iosifescu DV, Nierenberg AA, Alpert JE, et al.: The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry 2003, 160:2122–2127.PubMedCrossRefGoogle Scholar
  45. 45.
    Zheng D, Macera CA, Croft JB, et al.: Major depression and all-cause mortality among white adults in the United States. Ann Epidemiol 1997, 7:213–218.PubMedCrossRefGoogle Scholar
  46. 46.
    Jonas BS, Mussolino ME: Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000, 62:463–471.PubMedGoogle Scholar
  47. 47.
    Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819–1825.PubMedCrossRefGoogle Scholar
  48. 48.
    Horsten M, Mittleman MA, Wamala SP, et al.: Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study. Eur Heart J 2000, 21:1072–1080.PubMedCrossRefGoogle Scholar
  49. 49.
    Petitto JM, Evans DL: Depression in cancer and HIV infection: research findings and implications of effective antidepressant treatment. Depress Anxiety 1998, 8(Suppl 1):80–84.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Noel Kennedy
    • 1
  • Kevin Foy
  1. 1.St. Edmundsbury HospitalLucanRepublic of Ireland, UK

Personalised recommendations